Novo Nordisk A/S (NOVO-B.CO)

Copenhagen - Copenhagen Delayed Price. Currency in DKK
237.50-41.80 (-14.97%)
At close: 10:59 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close279.30
Bid237.60 x
Ask237.80 x
Day's Range224.20 - 245.20
52wk Range224.20 - 406.70
1y Target EstN/A
Market Cap598.37B
P/E Ratio (ttm)16.82
Avg Vol (3m)3,845,467
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Why Novo Nordisk A/S Got Crushed Today
    Motley Fool25 minutes ago

    Why Novo Nordisk A/S Got Crushed Today

    The diabetes specialist cuts short- and long-term growth outlooks.

  • Reuters4 hours ago

    European shares back in the red for October on weak results

    Earnings disappointments from the likes of Novo Nordisk soured the mood, with the stock down 15 percent, the worst performance across the STOXX 600 on the day. Concerns over the outlook for regional companies have led to a record 38 straight weeks of outflows from European equity funds, the latest data from Bank of America Merrill Lynch and fund tracker EPFR showed. Banks, among the most beaten down sectors in Europe this year, have offered some support to regional markets this week following a strong set of results from bellwethers which included a surprise profit at Deutsche Bank.

  • Bloomberg5 hours ago

    Diabetes Strategies the Difference for Novo, Sanofi

    Diabetes drug pricing pressure in the U.S. lead Novo Nordisk to slash its long-term profit growth target while Sanofi raised its earnings forecast. Bloomberg's Kristen Hallam examines the strategies of ...